Tumor motion changes in stereotactic body radiotherapy for liver tumors: an evaluation based on four-dimensional cone-beam computed tomography and fiducial markers-Reference-Cited by-同舟云学术

Tumor motion changes in stereotactic body radiotherapy for liver tumors: an evaluation based on four-dimensional cone-beam computed tomography and fiducial markers

Published:2017-03-23 Issue:1 Volume:12 Page:
ISSN:1748-717X
Container-title:Radiation Oncology
language:en
Short-container-title:Radiat Oncol

Author:

Shimohigashi Yoshinobu,Toya Ryo,Saito Tetsuo,Ikeda Osamu,Maruyama Masato,Yonemura Keisuke,Nakaguchi Yuji,Kai Yudai,Yamashita Yasuyuki,Oya Natsuo,Araki Fujio

Funder

JSPS KAKENHI

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s13014-017-0799-7.pdf

Reference21 articles.

1. Wulf J, Guckenberger M, Haedinger U, Oppitz U, Mueller G, Baier K, et al. Stereotactic radiotherapy of primary liver cancer and hepatic metastases. Acta Oncol. 2006;45:838–47.

2. Kitamura K, Shirato H, Seppenwoolde Y, Shimizu T, Kodama Y, Endo H, et al. Tumor location, cirrhosis, and surgical history contribute to tumor movement in the liver, as measured during stereotactic irradiation using a real-time tumor-tracking radiotherapy. Int J Radiat Oncol Biol Phys. 2003;56:221–8.

3. Guckenberger M, Sweeney RA, Wilbert J, Krieger T, Richter A, Baier K, et al. Image-guided radiotherapy for liver cancer using respiratory correlated computed tomography and cone-beam computed tomography. Int J Radiat Oncol Biol Phys. 2008;71:297–304.